|Day Low/High||135.53 / 137.06|
|52 Wk Low/High||101.58 / 146.31|
But we could see more volatility in the market.
It’s not easy for value investors to gain exposure to the growth-fueled and often-pricey biotech sector.
There is building consensus around a September rate hike.
Hospitals, biotechs and drug makers continue to hold their own.
Many of these firms are pouring money into share buybacks -- instead of their long-term pipelines.
On every single dollar in the futures, these stocks act as if it's the end of the world or beginning of a major ascent.